期刊文献+

5氟尿嘧啶上调干细胞标记物CD133在结肠癌细胞中的表达 被引量:10

5-FU upregulates stem cell marker CD133 expression in colon cancer cells
在线阅读 下载PDF
导出
摘要 目的:研究通过5氟尿嘧啶(5-FU)对结肠癌干细胞标记物CD133表达的影响,探讨5-FU对结肠癌干细胞的影响。方法:用流式细胞仪检测CD133在结肠癌细胞株表面的表达,磁珠细胞分离的方法分离结肠癌细胞株DLD1中CD133阳性和阴性的细胞群,细胞克隆形成实验检测2群细胞的自我更新能力,新型四唑氮盐方法(MTS)检测2群细胞对5-FU敏感性的差异,qPCR方法检测5-FU处理结肠癌细胞后CD133 mRNA水平的变化。结果:结肠癌细胞株DLD1、HT29、SW480、HCT116、Lovo、RKO细胞表面CD133的表达率分别为30.20%、82.00%、0.34%、91.80%、85.30%、0.28%。DLD1细胞中以CD133为标记有2群明显的细胞,MACS方法分离后阳性细胞群中CD133为87.21%±5.33%,而阴性细胞群中阴性细胞的比例为84.30%±4.65%;CD133阳性的细胞与未分离及CD133阴性细胞相比,克隆形成能力强(46.33%±4.44%vs31.00%±2.00%,P<0.05),对5-FU的敏感性下降20%,P<0.01。在DLD1和HT29细胞中,5-FU1mg/L上调CD133 mRNA水平的表达,从1升为1.684±0.012(P<0.01)、HT29细胞从30.702±0.284升为49.379±0.460(P<0.01)。结论:与CD133阴性细胞相比CD133阳性细胞克隆形成能力强,对5-FU的敏感性下降;5-FU上调干细胞标记物CD133 mRNA水平的表达,CD133阳性的结肠癌干细胞在5-FU的治疗过程中被富集。 AIM : To investigate the effect of 5 - fluorouracil ( 5 - FU) on the expression of the stem cell marker CD133 on colon cancer stem cells. METHODS: CD133 expression on several colon cancer cell lines was detected by flow cytometry. The CD133 positive cells from DLD1 cells were separated by the method of magnetic activated cell separation. Colony assay was used to measure self - renew ability and MTS assay was used to detect the sensitivity to 5 - FU after separation. After 5 - FU treatment, the change of CD133 mRNA level was measured by qPCR. RESULTS: CD133 expression on the surface of colon cacner cell lines DLD1, HT29, SW480, HCT116, Lovo, RKO was 30. 20% , 82.00% , 0. 34% , 91.80%, 85.30%, 0. 28% respectively. DLDI cells had two obvious populations according to CD133 expression. CD133 positive cells were separated from DLD1 cells, the positive purity was 87. 21% ± 5.33% and the negative purity was 84. 30% ±4. 65%. CD133 positive cells formed more colonies with limited dilution colony assay(46. 33% ±4. 44% vs 31.00%±2.00%, P 〈0. 05). CD133 positive cells were less sensitive to 5 - FU compared to CD133 negative cells(20% less, P 〈0. 01 ). 5 - FU at concentration of 1 mg/L upregulated CD133 mRNA expression in both DLD1 and HT29 cells, the relative quantity was increased from 1 to 1. 684 ±0. 012(P 〈0. 01 )and 30. 702±0. 280 to 49. 379 ±0. 460(P 〈0. 01 ) in HT29 and DLDI, respectively. CONCLUSION: Compared to CD133 negative cells, CD133 positive cells show more ability to form colonies in vitro, and are less sensitive to 5 - FU. 5 - FU upregulats the mRNA expression of CD133, resul- ting in the CD133 colon cancer stem cells enrichment during 5 - FU treatment.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第11期2187-2191,共5页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金博士启动资助项目(No.06300805)
关键词 结肠肿瘤干细胞 CD133 氟尿嘧啶 Colon neoplasm stem cells CD133 Fluorouracil
作者简介 Tel:020-38250745:E-mail:littleqicat@163.com
  • 相关文献

参考文献12

  • 1邓艳红,兰平.综合治疗对中低位直肠癌功能保护的意义[J].中华胃肠外科杂志,2007,10(4):396-398. 被引量:4
  • 2Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [ J ]. N Engl J Med, 2004, 350(23) : 2335 -2342.
  • 3Ricci- Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human coloncancer - initiating cells[J]. Nature, 2007, 445(123) : 111 - 115.
  • 4Lin E, Jiang Y, Deng Y, et al. Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited[J]. GCR, 2008, 2(4) : 169 - 174.
  • 5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006, 56(2): 106-130.
  • 6Hirai I, Kimura W, Fuse A, et al. Surgical management for metastatic liver[ J ]. Hepatogastroenterology, 2006, 53 (71) : 757 -763.
  • 7郭运杰,崔秀英,姚和瑞.乳腺癌细胞株MCF-7/ADM中肿瘤干细胞的研究[J].中国病理生理杂志,2008,24(12):2374-2377. 被引量:11
  • 8Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment[J]. J Pathol, 2008, 214(1): 3 -9.
  • 9Hombach - Klonisch S, Panigrahi S, Rashedi I, et al. Adult stem cells and their trans - differentiation potential perspectives and therapeutic applications [ J ]. J Mol Med, 2008, 86(12) : 1301 -1314.
  • 10Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J]. Nature, 2006, 444(7120) : 756 - 760.

二级参考文献31

  • 1邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
  • 2钟秀风,李永平,葛坚,黄冰,彭福华,杜建阳,林建贤,伍忠銮,刘敬波.人视网膜母细胞瘤肿瘤干细胞的分离培养[J].中国病理生理杂志,2006,22(6):1177-1181. 被引量:19
  • 3肖毅,吴斌,林国乐,邱辉忠.中低位直肠癌的新辅助治疗[J].肿瘤学杂志,2006,12(3):169-171. 被引量:4
  • 4Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [ J ]. Nat Rev Cancer,2005,5 (4) :275 - 284.
  • 5Phillips TM, McBride WH, Pajonk F. The response of CD24( -/low)/CD44 + breast cancer - initiating cells to radiation [ J ]. J Natl Cancer Inst, 2006, 98 ( 24 ) : 1777 - 1785.
  • 6Sheridan C, Kishimoto H, Fuchs RK, et al. CD44^+/CD24^- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis [ J ]. Breast Cancer Rcs,2006,8 (5) :R59.
  • 7Al- Hajj M. Cancer stem cells and oncology therapeutics [J]. Curr Opin Oncol,2007,19( 1 ) :61 -64.
  • 8Kondo T, Setoguchi T,Taga T. Persistence of a small subpopulation of cancer stem - like cells in the C6 glioma cell line[J]. PNAS,2004,101(3) : 781 -786.
  • 9Ponti D, Costa A, Zaffaroni N,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties [ J ]. Cancer Res, 2005, 65 (13) :5506 -5511.
  • 10Yu F, Yao H, Zhu P, et al. let - 7 regulates self - renewal and tumorigenesis of breast cancer cells [ J ]. Cell, 2007,131 (6) :1109 - 1123.

共引文献13

同被引文献104

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部